BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ toTreat Parkinson's Disease
false
áøééðñååéé áò"î
2
380
BRAINSWAY LTD
Corporation no:
513890764
10767
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
02/04/2024
www.isa.gov.il
www.tase.co.il
Reference:
2024-02-037602
Time of broadcast:
14:31
14:31
The corporation scheduled the publication of the report to
04/04/2024 15:00
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
BrainsWay_Review_Results_Parkinsons_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
BWAY
Date of revision of form structure:
20/02/2024
Address:
äøèåí
19
,
éøåùìéí
91451
,
Tel:
02-5813140
,
Fax:
02-5812517
E-mail address:
uri@Brainsway.com
Company site:
www.Brainsway.com
Previous names of reporting entity:
Name of the Signatory:
Levy Hadar
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Address:
Hartum Street, Bynet Building
19
,
Jerusalem
9777518
Telephone:
97225824030
Facsimile:
97225812517
E-mail:
hadarl@brainsway.com
1